235 related articles for article (PubMed ID: 19207871)
1. Hepatitis B vaccination in haemodialysis patients: a randomized clinical trial.
Bock M; Barros E; Veronese FJ
Nephrology (Carlton); 2009 Apr; 14(3):267-72. PubMed ID: 19207871
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients.
Ramezani A; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
Int J Clin Pract; 2009 Mar; 63(3):394-7. PubMed ID: 18005039
[TBL] [Abstract][Full Text] [Related]
3. Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease.
Weinstein T; Chagnac A; Boaz M; Ori Y; Herman M; Zevin D; Schmilovitz-Weiss H; Gafter U
Nephron Clin Pract; 2004; 97(2):c67-72. PubMed ID: 15218332
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
[TBL] [Abstract][Full Text] [Related]
5. Intracutaneous versus intramuscular hepatitis B vaccination in primary non-responding haemodialysis patients.
Chang PC; Schrander-van der Meer AM; van Dorp WT; van Leer E
Nephrol Dial Transplant; 1996 Jan; 11(1):191-3. PubMed ID: 8649634
[TBL] [Abstract][Full Text] [Related]
6. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
Radziszewski A; Gajda M; Pituch-Noworolska A; Drozdz M; Kraśniak A; Kaczmarczyk I; Hołyś S; Zurowski J; Sydor A; Sułowicz W
Przegl Lek; 2007; 64(7-8):470-5. PubMed ID: 18409347
[TBL] [Abstract][Full Text] [Related]
7. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous vaccination against hepatitis A and B: results of an open, randomized study from the occupational health point of view.
Rieger MA; Hofmann F; Michaelis M
Int J Occup Med Environ Health; 2004; 17(3):379-91. PubMed ID: 15683159
[TBL] [Abstract][Full Text] [Related]
9. Primary high-dose intradermal hepatitis B vaccination in hemodialysis: cost-effectiveness evaluation at 2 years.
Mat O; Mestrez F; Beauwens R; Muniz-Martinez MC; Dhaene M
Hemodial Int; 2006 Jan; 10(1):49-55. PubMed ID: 16441827
[TBL] [Abstract][Full Text] [Related]
10. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
Jafarzadeh A; Zarei S; Shokri F
Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
[TBL] [Abstract][Full Text] [Related]
11. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis.
Liu YL; Kao MT; Huang CC
Vaccine; 2005 Jun; 23(30):3957-60. PubMed ID: 15917117
[TBL] [Abstract][Full Text] [Related]
12. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up.
Morais EO; Resende MR; Oliveira AM; Sinkoc VM; Garcia MT; Angerami RN; da Silva LJ
Aliment Pharmacol Ther; 2007 Apr; 25(7):849-55. PubMed ID: 17373924
[TBL] [Abstract][Full Text] [Related]
13. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
14. A randomised controlled trial of intradermal hepatitis B vaccination and augmentation of response with erythropoietin.
Anandh U; Thomas PP; Shastry JC; Jacob CK
J Assoc Physicians India; 2000 Nov; 48(11):1061-3. PubMed ID: 11310381
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules.
McNulty CA; Bowen JK; Williams AJ
Vaccine; 2005 Jul; 23(32):4142-7. PubMed ID: 15913854
[TBL] [Abstract][Full Text] [Related]
16. Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients.
Sali S; Alavian SM; Hajarizadeh B
Nephrology (Carlton); 2008 Oct; 13(5):376-9. PubMed ID: 18518938
[TBL] [Abstract][Full Text] [Related]
17. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
18. Persistence of hepatitis B vaccine immunity in hemodialysis patients.
Ramezani A; Velayati AA; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
Ther Apher Dial; 2008 Apr; 12(2):143-6. PubMed ID: 18387163
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of a recombinant hepatitis B vaccine in haemodialysis patients.
Bruguera M; Cremades M; Mayor A; Sánchez Tapias JM; Rodés J
Postgrad Med J; 1987; 63 Suppl 2():155-8. PubMed ID: 3317354
[TBL] [Abstract][Full Text] [Related]
20. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
Sorkhi H; Dooki MR; Ebrahimnejad MS
J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
